About
Us
01
Vision
Who we are
Pioneering MEGGABIOTICS: Revolutionizing Gut Health Through Targeted Antibody Therapy
Harnessing Nature’s Wisdom for 28 Years
For 28 years, we’ve dedicated ourselves to solving one of biotechnology’s greatest challenges: How do you safely and effectively restore balance to the human microbiome? Our answer—MEGGABIOTICS—is a paradigm-shifting innovation with the power to treat, prevent, and potentially cure diseases once deemed untouchable.
What is MEGGABIOTICS?
MEGGABIOTICS.com – Your Gateway to Understanding the Future of Gut Health
A first-of-its-kind therapy, MEGGABIOTICS (Microbiome EGG Antibody Therapy) uses highly targeted IgY antibodies, naturally produced by hyperimmunized hens and delivered orally via whole egg powder. Unlike antibiotics that destroy bacteria indiscriminately, or probiotics that add microbes, MEGGABIOTICS:
Neutralizes harmful pathogens with precision, allowing the gut’s native “good” bacteria to thrive.
Delivers nutritional benefits through egg-derived proteins, vitamins and minerals.
Operates safely with minimal side effects, leveraging nature’s own bioreactors (hens) for sustainable production.
Why MEGGABIOTICS Changes Everything
MEGGABIOTICS transcends traditional “biotic” approaches to address chronic diseases at their root.
Proven Track Record: In 2007, we launched the world’s first registered veterinary biologic to prevent E. coli diarrhea in livestock—validating our science at scale.
Human Health Breakthrough: Currently in Phase 2 clinical trials for C. difficile infections, with potential applications for chronic inflammatory conditions, autoimmune disorders, and beyond.
A New Category of Care: Positioned at the intersection of biologics, nutrition, and microbiome science, MEGGABIOTICS transcends traditional “biotic” classifications.
For Stakeholders: Clarity Meets Innovation
We simplify the complex for every audience:
Investors: Back a patented, scalable platform with dual applications in human and veterinary medicine.
Healthcare Providers: Access a non-invasive, gut-targeted therapy that complements existing treatments.
Patients: Benefit from a safe, nutritionally enhanced solution that addresses root causes, not just symptoms.
Our Vision
To redefine microbiome health globally—transforming how chronic diseases are treated and prevented through nature-inspired science.
Partner With Us
Explore Licensing Opportunities: Leverage our patented IgY antibody technology for therapeutic or preventive applications.
Invest in Impact: Support clinical trials and pipeline expansion into autoimmune, metabolic, and inflammatory diseases.
Collaborate: Join academic and industry partners in advancing microbiome research.
02
People
Founder
John Hare
Founder
